GLENVIEW CAPITAL MANAGEMENT LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:16 pm Sale |
2024-09-30 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 1,261,530 1.390% |
-4,022,452 (-76.13%) |
Filing |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 5,283,982 5.970% |
971,851 (+22.54%) |
Filing |
| 2023-03-01 4:10 pm Purchase |
2023-02-24 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 4,312,131 5.310% |
4,312,131 (New Position) |
Filing |